Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.
[[thumbnail_alt_text]]
In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
[[thumbnail_alt_text]]
An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.
[[thumbnail_alt_text]]
There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.
[[thumbnail_alt_text]]
Research suggests that those with progressive multiple sclerosis may have adjusted more effectively to lockdown conditions.
 
[[thumbnail_alt_text]]
Although there is no underlying mechanism specifically associating cognitive and visual impairment, the investigators noted that the relationship between cognitive and visual function is likely bidirectional and multifactorial. 
[[thumbnail_alt_text]]
Post-menopausal women are at a heightened risk of Alzheimer disease.

 
[[thumbnail_alt_text]]
Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.
[[thumbnail_alt_text]]
Flavonoids are natural substances found in plants, including fruits and vegetables, and are associated with various health benefits, such as reduced inflammation.
[[thumbnail_alt_text]]
Contrary to previous studies, the rate of cognitive impairment has increased over the past 20 years. 
[[thumbnail_alt_text]]
The FDA has approved Nurtec ODT (rimegepant) from Biohaven Pharmaceuticals to treat acute migraines with or without aura in adults.
[[thumbnail_alt_text]]
A new medication for certain rare blood cancers has now become available through a limited distribution with AllianceRx Walgreens Prime.